Home

DARLENE M DEPTULA-HICKS

CIK 1089409 · See Remarks · last filed 2026-06-11

DARLENE M DEPTULA-HICKS is a corporate insider who has filed 24 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for ALDX, was dated Jun 11, 2026. Across all open-market trades the lifetime net is −$12.4K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

6

Total Filings

24

Lifetime Open-Market Net

-$12.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALDX Director — $1.51 — $0 1 2026-06-11
F-star Therapeutics, Inc. (FSTX) Delisted See Remarks 25,539 $7.12 $181.8K $0 7 2023-03-09
XBIO Director — $3.22 — $0 2 2017-06-15
T2 Biosystems, Inc. (TTOO) Delisted SVP & Chief Financial Officer 1 $0.00 $0 $14.3K 2 2017-06-08
PALVELLA THERAPEUTICS, INC. (PIRS) Delisted SVP, Chief Financial Officer 62 $13.60 $843 $8.3K 2 2016-06-15
ICAD INC (ICAD) Delisted Exec VP of Finance, CFO 25,011 $3.87 $96.8K -$35.0K 10 2011-03-31

Recent Filings

24 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-11 ALDX Grant (A) — $0 EDGAR
2023-03-09 F-star Therapeutics, Inc. (FSTX) Delisted Mixed −56,437 -$401.8K EDGAR
2022-04-04 F-star Therapeutics, Inc. (FSTX) Delisted Grant (A) — $0 EDGAR
2022-01-11 F-star Therapeutics, Inc. (FSTX) Delisted Grant (A) — $0 EDGAR
2021-08-24 F-star Therapeutics, Inc. (FSTX) Delisted Grant (A) +26,437 $0 EDGAR
2021-03-11 F-star Therapeutics, Inc. (FSTX) Delisted Grant (A) — $0 EDGAR
2021-02-02 F-star Therapeutics, Inc. (FSTX) Delisted Grant (A) +30,000 $0 EDGAR
2020-11-24 F-star Therapeutics, Inc. (FSTX) Delisted Grant (A) — $0 EDGAR
2017-06-15 XBIO Grant (A) — $0 EDGAR
2017-06-08 T2 Biosystems, Inc. (TTOO) Delisted Buy (P) +4,000 $14.3K EDGAR
Showing 1–10 of 24
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.